Vaxxinity, Inc. — key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2023)

-$56.9M

Total Assets (FY2023)

$44.3M

Total Equity (FY2023)

$13.4M

Cash Flows from Operating Activities (FY2023)

-$57.2M

Source: Vaxxinity, Inc. 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.